Lionel Messi could be set to extend his contract at Barcelona.
The six-time Ballon d'Or winner's deal with the LaLiga giants expires next year, and there has been some speculation about the forward's future.
But, a renewal at Barcelona could be on the cards.
TOP STORY – BARCELONA TO BEGIN CONTRACT TALKS WITH MESSI
Barcelona president Josep Maria Bartomeu is planning to meet Messi's father next week to discuss a contract renewal, according to Sport.
The 32-year-old has won 10 LaLiga titles and the Champions League on four occasions during his time at Barca.
Meanwhile, Sport also reports Barcelona rejected a €100million offer for 17-year-old forward Ansu Fati.
- While RB Leipzig star Timo Werner is reportedly set to join Chelsea, it seems Liverpool may be looking elsewhere. The Independent says Liverpool are closely monitoring Borussia Dortmund attacker Jadon Sancho. The England international has been linked to Manchester United and Real Madrid. The Mirror, meanwhile, reports Liverpool manager Jurgen Klopp called Werner to tell the forward the club would not be pursuing a move.
- Barcelona are expected to be busy during the close season. Marca reports the LaLiga giants are still focused on Inter star Lautaro Martinez and Juventus midfielder Miralem Pjanic, despite the transfers being complicated.
- Staying at Camp Nou and Sport reports Bayern Munich consider Barcelona defender Nelson Semedo, valued at €40m, too expensive, with Ajax's Sergino Dest a cheaper alternative.
- Out of contract at Paris Saint-Germain at season's end, Thiago Silva could be set for an exit. The defender is open to a return to AC Milan if he does not renew in Paris, according to Sport.
- Another player coming out of contract, Dries Mertens, is seemingly going nowhere. Sky Sport reports Mertens, 33, will extend his contract with Napoli for two years with an option for a third.
- Could Chelsea add a left-back this close season? The Guardian says they are stepping up their interest in Leicester City defender Ben Chilwell, while Ajax's Nicolas Tagliafico is said to be an alternative.